SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Psoriasis/Chronic Inflammation
An SI Board Since February 2001
Posts SubjectMarks Bans
631 42 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
231Thanks!! question thrown out for the thread...... So, is there any evidence thscaram(o)uche-6/5/2002
230MX-1094,...delivery mechanism that gets the standard NSAID past the gastrointestrusset-6/5/2002
229[Medinox/NSAID prodrug] Designed to address the same concerns as COX-2 inhibitoscaram(o)uche-6/5/2002
228Biogen stock off after FDA documents posted (BGEN) By Ted Griffith Shares of BioArthur Radley-5/22/2002
227Biogen Is `Guardedly Optimistic' Amevive Will Get Approval from FDA Panel ByArthur Radley-5/21/2002
226SANG / RDP58 / Ulcerative Colitis FREMONT, Calif.--(BW HealthWire)--May 21, 200nigel bates-5/21/2002
225Guy is getting a little classier all the time. No silly mention of the one B lyscaram(o)uche-5/20/2002
224Biogen, and All of Biotech, Wait Anxiously for Amevive Verdict By Adam FeuersteArthur Radley-5/20/2002
223Rick, As always...thanks for the detailed response to my questions about MEDI/BTArthur Radley-5/18/2002
222Anybody watching the SID meeting? Ligand did a PR relating to this abstract: &tuck-5/17/2002
221>> My comments were totally directed toward ABGX...as being bad for them. scaram(o)uche-5/15/2002
220Rick, My comments were totally directed toward ABGX...as being bad for them. CerArthur Radley-5/14/2002
219>> Well...since you retracted the friggin comment...I will remove the asshscaram(o)uche-5/14/2002
218Well...since you retracted the friggin comment...I will remove the asshole commeArthur Radley-5/14/2002
217Good news is foreseen news, no?scaram(o)uche-5/14/2002
216Duh! Tuesday May 14, 4:07 pm Eastern Time Press Release SOURCE: Abgenix Phase 2scaram(o)uche-5/14/2002
215Not good news IMO... Another psoriasis candidate bites the dust... Tuesday May Arthur Radley-5/14/2002
214ABGX going nuts after hours on expected anti-IL-8 news. Crazy. Jerks, keeping scaram(o)uche-5/14/2002
2136 Novel Anti-Inflammatory Drug Candidates to be Featured at Inflammation In Drugkeokalani'nui-5/14/2002
21211 Amevive abstracts. sidnet.org SORRY THE LINK ABOVE DOES NOT LEAD TO THEM BUaknahow-5/10/2002
211Imp Dermatology Meeting Next Week by: juliusgylys aknahow-5/10/2002
210[ PDLI/anti-IFNgamma ] Wednesday May 8, 4:00 pm Eastern Time Press Release SOURscaram(o)uche-5/8/2002
209you're outta here. sorry, this is a scrap book that is used for reference, scaram(o)uche-5/1/2002
208Isotechnika Inc. (ISA-T) C$4.97 Preliminary Phase II-A Kidney Transplant Resultsteevee-5/1/2002
207ISA's drug ISAtx247 has a broad therapeutic window and apparently early resuteevee-4/30/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News